KDR and neoplasm: A substantial body of evidence has emerged suggesting that the axis between the vascular endothelial growth factor (VEGF) receptor and the Flk-1 kinase insert domain receptor (KDR) (VEGF-Flk-1/KDR) is the dominant signal transduction pathway regulating tumor angiogenesis and metastasis [13].